Buy or sell Membrion stock pre IPO via an EquityZen fund
EquityZen is a marketplace for shares of proven pre IPO tech companies

Membrion Stock
A Seattle, WA-based manufacturer of ultra-low cost, high performance ion exchange membranes.
About Membrion Stock
Membrion™ is a 2016 spin-out from the laboratories of the University of Washington (UW). Commercialization funding from the UW, the Murdock Charitable Trust, Amazon, the National Science Foundation (Award #1648517) and a consortium of California utilities (Rocket Fund) has helped to bridge the translation gap to a commercial product. In total, 11 different funding organizations have evaluated and financially supported Membrion's product development and commercialization plan. Most recently, that support has translated to private investment by angel investors as they scale their technology into commercial production.
Funding History
September 2018 | $748K |
---|---|
September 2018 | $1.0M |
December 2018 | $485K |
February 2019 | $3.1M |
Management
CTO
Greg Newbloom
President & CEO
John Plaza
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase